期刊文献+

尼美舒利固体分散体的制备及其性质考察 被引量:6

Preparation and evaluation of nimesulide solid dispersion
下载PDF
导出
摘要 目的提高尼美舒利释放速率及生物利用度。方法分别以聚乙二醇(PEG)、聚乙烯吡咯烷酮(PVP k30)及泊洛沙姆188为载体,采用熔融法、溶剂法及溶剂-熔融法等制备尼美舒利固体分散体;考察载体类别及载体-药物质量比对释放的影响;配合差示扫描量热(DSC)分析与电子扫描电镜(SEM)观察考察药物在载体中的存在状态。结果尼美舒利以无定型状态存在于固体分散体中,载体类别不同、载体-药物质量比不同,药物的释放度不同。结论将尼美舒利制成固体分散体能显著增加尼美舒利的体外释放度。 Objective To prepare and identify nimesulide solid dispersion, and determine its dissolution property. Methods The hot melt, solvent and solvent-hot melt methods, with several different cartier materials (PEG, PVP k30 and Poloxamer 188 ), were used for preparation and differential scanning calorimetry (DSC) and scanning electron microscopy (SEM) for identification of nimesulide solid dispersion. The dissolution of the dispersion was determined with paddle method. Results The study showed that nimesulide in solid dispersion could be dispersed in carriers materials with amorphous stabilities. Conclusions The dissolution of nimesulide is increased by solid dispersion method.
出处 《沈阳药科大学学报》 CAS CSCD 北大核心 2009年第2期93-97,共5页 Journal of Shenyang Pharmaceutical University
关键词 尼美舒利 固体分散体 聚乙二醇 差示扫描量热法 电子扫描电镜 nimesulide solid dispersion polyethylene glycol differential scanning calorimetry scanning electron microscopy
  • 相关文献

参考文献8

  • 1杨世亭,傅得兴.非甾体抗炎新药——尼美舒利[J].中国药学杂志,1998,33(6):377-378. 被引量:17
  • 2FAMAEY J P. In vitro and in vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by rtimesulide: An overview [J]. Inflamm-Res, 1997,46 (11) :437 -446.
  • 3SENNAG E P, ACQUA G, ANDRI G, et al. Nimesutide in the treatment of patients into learnt of aspirin and other NSAIDs [ J ]. Drug Saf, 1996, 14 ( 2 ) : 94 - 103.
  • 4ANDRI L, SENNA G, BETTELI C, et al. Tolerability of nimesulide in aspirin sensitive patients[ J]. Ann Allergy, 1994,72 ( 1 ) :29 - 32.
  • 5TANIGUCHI Y, YOKOYAMA K, ZNUI K, et al. Inhibition of brain cyclooxygenase-2 activity and the antipytetic action ofnimesulide[ J]. Eur J Pharmcol, 1997, 330(2/3 ) :221 - 229.
  • 6WARD A, BROGDEN R. Nirnesulide, a preliminary review of its pharmacological properties and therapeutic efficacy in inflammation and pain ststes [ J ]. Drugs, 1988,36:732 - 753.
  • 7沈松,徐希明,余江南.难溶性药物的增溶及其缓/控释制剂研究进展[J].中国药事,2007,21(3):196-200. 被引量:18
  • 8刁雨辉,顾新.尼美舒利片在不同介质中的溶出度比较[J].中国医院药学杂志,2001,21(3):154-155. 被引量:6

二级参考文献27

共引文献37

同被引文献50

引证文献6

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部